Abiopharma

📋 KUMAR HALDEA FAMILY IRREVOCABLE TRUST (Director) plans to sell 100K shares of BridgeBio Pharma, Inc. (at $74.27 each, total $7.4M) Filed: Jan 08, 2026 | ID: 000275

New Form 5 - NovoCure Ltd Filed: 2026-01-08 AccNo: 0001997032-26-000001 Size: 5 KB

📋 The Jeffrey W. Dunn Living Trust (Director) plans to sell 60K shares of SI-BONE, INC. (at $21.40 each, total $1.3M) Filed: Jan 08, 2026 | ID: 000274

New Form 5 - NovoCure Ltd Filed: 2026-01-08 AccNo: 0001654435-26-000001 Size: 5 KB

📋 Utter Christine Marie (Officer) plans to sell 1K shares of PTC THERAPEUTICS, INC. (at $76.45 each, total $79K) Filed: Jan 08, 2026 | ID: 000220

New Form 5 - NovoCure Ltd Filed: 2026-01-08 AccNo: 0001917165-26-000001 Size: 5 KB

📋 Linetsky David (Officer) plans to sell 6K shares of Phreesia, Inc. (at $17.01 each, total $104K) Filed: Jan 08, 2026 | ID: 000219

(30% Negative) Tilray Brands, Inc. (TLRY) Reports Q1 2026 Financial Results

Director Watts Ryan J. 🔴 sold 35.2K shares of Denali Therapeutics Inc. (DNLI) at $16.50 Transaction Date: Jan 06, 2026 | Filing ID: 000004

Director Brunn Carsten 🔴 sold 23.8K shares of Cartesian Therapeutics, Inc. (RNAC) at $6.82 Transaction Date: Jan 06, 2026 | Filing ID: 000047

Envista Schedules Fourth Quarter 2025 Earnings Call

Miljkovic Milos 🔴 sold 3.6K shares of Cartesian Therapeutics, Inc. (RNAC) at $6.82 Transaction Date: Jan 06, 2026 | Filing ID: 000046

Davis Blaine 🔴 sold 10.6K shares of Cartesian Therapeutics, Inc. (RNAC) at $6.82 Transaction Date: Jan 06, 2026 | Filing ID: 000045

Schuth Alexander O. 🔴 sold 17.2K shares of Denali Therapeutics Inc. (DNLI) at $16.50 Transaction Date: Jan 06, 2026 | Filing ID: 000005

New Form 424B3 - GT Biopharma, Inc. Filed: 2026-01-08 AccNo: 0001493152-26-000976 Size: 10 KB